Ying-ying Zhang

Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Telomerase reverse transcriptase gene knock-in unleashes enhanced longevity and accelerated damage repair in mice.

Telomerase reverse transcriptase gene knock-in unleashes enhanced longevity and accelerated damage repair in mice.

Journal: Aging cell

Published: April 22, 2024

Hypomethylation of MIR-378 5'-flanking region predicts poor survival in young patients with myelodysplastic syndrome.

Hypomethylation of MIR-378 5'-flanking region predicts poor survival in young patients with myelodysplastic syndrome.

Journal: Molecular genetics & genomic medicine

Published: August 07, 2019

Intragenic hypomethylation of DNMT3A in patients with myelodysplastic syndrome.

Intragenic hypomethylation of DNMT3A in patients with myelodysplastic syndrome.

Journal: Clinical chemistry and laboratory medicine

Published: February 22, 2017

Puerarin promotes the viability and differentiation of MC3T3‑E1 cells by miR‑204‑regulated Runx2 upregulation.

Puerarin promotes the viability and differentiation of MC3T3‑E1 cells by miR‑204‑regulated Runx2 upregulation.

Journal: Molecular medicine reports

Published: August 26, 2016

Methylation of miR-378 in Chronic Myeloid Leukemia

Methylation of miR-378 in Chronic Myeloid Leukemia

Journal: Zhongguo shi yan xue ye xue za zhi

Published: February 26, 2016

High expression of OCT4 is frequent and may cause undesirable treatment outcomes in patients with acute myeloid leukemia.

High expression of OCT4 is frequent and may cause undesirable treatment outcomes in patients with acute myeloid leukemia.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: May 25, 2015

DNMT3A intragenic hypomethylation is associated with adverse prognosis in acute myeloid leukemia.

DNMT3A intragenic hypomethylation is associated with adverse prognosis in acute myeloid leukemia.

Journal: Leukemia research

Published: March 31, 2015

Let-7a-3 hypomethylation is associated with favorable/intermediate karyotypes but not with survival in acute myeloid leukemia.

Let-7a-3 hypomethylation is associated with favorable/intermediate karyotypes but not with survival in acute myeloid leukemia.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: March 28, 2015

GPX3 promoter is methylated in chronic myeloid leukemia.

GPX3 promoter is methylated in chronic myeloid leukemia.

Journal: International journal of clinical and experimental pathology

Published: March 18, 2015

The 5' flanking region of miR-378 is hypomethylated in acute myeloid leukemia.

The 5' flanking region of miR-378 is hypomethylated in acute myeloid leukemia.

Journal: International journal of clinical and experimental pathology

Published: March 11, 2015

CEBPA methylation and mutation in myelodysplastic syndrome.

CEBPA methylation and mutation in myelodysplastic syndrome.

Journal: Medical oncology (Northwood, London, England)

Published: February 10, 2015

GPX3 hypermethylation serves as an independent prognostic biomarker in non-M3 acute myeloid leukemia.

GPX3 hypermethylation serves as an independent prognostic biomarker in non-M3 acute myeloid leukemia.

Journal: American journal of cancer research

Published: February 06, 2015

Showing 1-12 of 21

Last Updated: 09/26/2026